Posted on: November 5, 2009 by PEHub AdministratorNo Comments »
TPG Capital and the Canada Pension Plan have agreed to buy IMS Health (NYSE: RX), a provider of data on prescription drug sales, for $22 per share (50% premium to last Friday’s closing price). The total deal would be valued at around $5.2 billion, including the assumption of debt. Goldman Sachs is providing the leveraged finance.
Welcome! Join the peHUB community to make connections, share your opinion, and follow your favorite authors. It's quick and easy.
Click here to get started!
Luisa Beltran wrote a new post, Slideshow: Number of M&A Deals Hits Summer Slow Down 4 minutes ago
Staff Reporter wrote a new post, Schoen Departs Thomas H. Lee Partners 2 hours, 27 minutes ago
Thomas H. Lee Partners L.P. has announced that Scott Schoen has stepped down as vice chairman of the firm. Schoen will remain a senior advisor to the firm. Schoen joined THL in 1986, served as co-president of the […]
Luisa Beltran wrote a new post, Will Private Equity Bid for the Yankees? Not So Fast 2 hours, 40 minutes ago
Will the Yankees, if they go up for sale, attract private equity?
According to the New York Daily News, rumors are “flying” in MLB and New York banking circles that the family that owns the Bronx Bombers is […]
Reuters News wrote a new post, Talbots Dumped by Sycamore, Shares Slump 2 hours, 46 minutes ago
Staff Reporter wrote a new post, Bazaarvoice Buys PowerReviews for $150M 2 hours, 47 minutes ago
Bazaarvoice has acquired venture-backed PowerReviews for roughly $150 million. Menlo Ventures, a lead investor and largest shareholder in PowerReviews, said that it scored a 3x return in the deal. Bazaarvoice is a […]
Staff Reporter wrote a new post, National Educational Music Buys School Musical Suppliers 3 hours, 1 minute ago
National Educational Music Co. has acquired the assets of School Musical Suppliers Inc., also known as City Music Center. New Jersey-based School Musical Suppliers is a band and orchestra musical instrument rental […]
Staff Reporter wrote a new post, PE-Backed Quest Specialty Chemicals Names CEO 3 hours, 5 minutes ago
Quest Specialty Chemicals, which is backed by Audax Group and Moelis Capital Partners, has named Doug Mattscheck as president and chief executive. Menomonee Falls, Wisc.-based Quest formulates and manufactures […]
Georges van Hoegaerden commented on the post, Why Facebook is Killing Silicon Valley 3 hours, 36 minutes ago
So really Steve, the title of your articles should have read: “How VCs are killing Silicon Valley”, and I’d wholeheartedly agree. Especially since their thesis determines what can be discovered (Einstein).
Georges
Staff Reporter wrote a new post, Safeguard Scientifics Adds Jarrett to Board 3 hours, 40 minutes ago
Publicly traded Safeguard Scientifics Inc. has named Dr. Keith B. Jarrett to its board. Jarrett is a principal of Rockport Funding, a specialty finance start-up company incubator.
PRESS RELEASE
Safeguard […]
Staff Reporter wrote a new post, Inerjys Adds Two Partners 3 hours, 45 minutes ago
Montreal-based growth equity fund Inerjys has added of Jigar Shah and Russell Pullan as partners. Shah joins Inerjys from the Carbon War Room, and was previously CEO of solar services firm SunEdison. Pullan joins […]
